Products for Research Use Only

Voglibose

CAT: 0013-GTR19159354-01Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19159354-01Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus. Postprandial hyperglycemia (PPHG) is primarily due to first phase insulin secretion. Alpha glucosidase inhibitors delay glucose absorption at the intestine level and thereby prevent sudden surge of glucose after a meal. There are three drugs which belong to this class, acarbose, miglitol and voglibose, of which voglibose is the newest. Voglibose has fewer side effects than both acarbose and miglitol. But acarbose has an edge over voglibose in terms of efficacy (FPG, PPHG, HBA1c) .
CAS Number
83480-29-9
Product Name Alternative
AO-128, AO 128, Glustat, Voglibose, Voglib
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
H2O : ≥ 200 mg/mL; 748.28 mM
Smiles
[C@]1 ([C@H] ([C@@H] ([C@H] ([C@H] (C1) NC (CO) CO) O) O) O) (O) CO
Molecular Formula
C10H21NO7
Molecular Weight
267.28
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(1S,2S,3R,4S,5S) -5- (1,3-dihydroxypropan-2-ylamino) -1- (hydroxymethyl) cyclohexane-1,2,3,4-tetraol

Popular Products